NAD+ IV Therapy in BC: What It Is, What the Evidence Says, and Where to Get It in Vancouver and British Columbia (2025)
Quick Answer
NAD+ IV therapy is a private wellness service available throughout British Columbia, with clinics in Vancouver, Victoria, Kelowna, and other cities offering infusions ranging from $350 to $1,200 per session. The treatment delivers nicotinamide adenine dinucleotide directly into the bloodstream, bypassing digestive absorption, though published human evidence comparing IV delivery to oral precursors remains limited. NAD+ IV therapy is not covered by MSP and requires no physician referral at most private clinics. Consult a qualified healthcare professional before pursuing any IV therapy, and use the BCMedicalAccess.ca directory to find vetted providers in your area.
Last Updated: May 26, 2026
Reviewed by Sarah K., MSc Health Sciences | BCMedicalAccess.ca Editorial Team
If you've followed David Sinclair's work on sirtuins, listened to Andrew Huberman discuss NAD+ precursors, or read about CD38-driven decline in cellular energy production, you've already done more reading than the average person walking into a Vancouver IV bar. That puts you in a complicated position: you understand the biology well enough to know NAD+ matters, but you've also seen enough hype-cycle marketing to be skeptical of any clinic promising "cellular rejuvenation" for $700 a drip.
This guide covers what NAD+ actually does, what the published human evidence on IV NAD+ does and doesn't show, what to expect at a session in BC, what it costs, and how to think about whether the spend is justified.
What Is NAD+ and Why Does It Matter for Longevity?
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It's the central currency of cellular redox metabolism, accepting hydride groups during the oxidation of carbohydrates, fats, and amino acids to produce ATP. Beyond energy metabolism, NAD+ is a substrate for two enzyme families that have driven most of the longevity-research interest: the sirtuins (SIRT1–7), which deacylate histones and other proteins to regulate inflammation, mitochondrial biogenesis, and DNA repair, and the PARPs, which use NAD+ in DNA damage response [1,2].
NAD+ levels decline substantially with age. Multiple mechanisms contribute: reduced biosynthesis pathway activity, and notably, increased activity of NAD+-consuming enzymes like CD38 [3]. The hypothesis driving the longevity field is straightforward: if NAD+ decline contributes to age-related dysfunction (cellular senescence, mitochondrial decay, impaired DNA repair), then restoring NAD+ should slow or partially reverse it. In rodents, this is well-supported. In humans, it's a hypothesis with growing, but still preliminary, evidence.
Oral precursors versus IV NAD+ is where the practical question begins. NAD+ itself isn't directly absorbed across the intestinal wall; you have to provide a precursor that the body converts. The two most-studied oral precursors are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both have demonstrated dose-dependent NAD+ elevation in humans. Trammell et al. (2016) showed oral NR raises blood NAD+ up to 2.7-fold [4], and Martens et al. (2018) showed 1,000 mg/day NR for six weeks raised peripheral blood mononuclear cell NAD+ by approximately 60% [5]. IV NAD+ bypasses the gut entirely, delivering the intact molecule directly to the bloodstream. The first published pharmacokinetic study of IV NAD+ in humans appeared only in 2019 [6]. Until then, despite NAD+ infusion being used clinically since 1961 for addiction recovery [7], its metabolic fate in humans was essentially unknown.
IV NAD+ vs. Oral Supplements: What the Evidence Says
This is the section where you have to separate biology from marketing. Both are real; the question is which matters for your decision.
On bioavailability: IV delivery achieves 100% bioavailability by definition, as the molecule enters circulation intact. Oral precursors are subject to first-pass metabolism, gut microbiome interference, and conversion through the salvage pathway before contributing to systemic NAD+ [8]. On paper, IV wins. In practice, the question that matters isn't "how much NAD+ enters the blood" but "how much NAD+ ends up in the tissues where you want it." Recent isotope-tracing work suggests the answer is more complicated than the simple bioavailability comparison implies. Much circulating NAD+ is rapidly metabolized to nicotinamide before tissue uptake, and oral precursors may reach some tissues (skeletal muscle, liver) more efficiently than the parent molecule does via IV [9].
On the human evidence specifically: the published RCT base for IV NAD+ is small. Grant et al. (2019) characterized the metabolome of 11 healthy men during a 6-hour IV NAD+ infusion, providing useful pharmacokinetic data but not an efficacy trial [6]. A 2024 placebo-controlled pilot RCT compared acute effects of pharmaceutical-grade IV NR (Niagen+) and IV NAD+ in healthy adults; both raised whole-blood NAD+, but the trial was small and short-term [10]. A 2026 Frontiers in Aging study noted that no published trials directly compare clinical outcomes between IV and oral routes [8]. That last point is worth sitting with: there is currently no published head-to-head human trial demonstrating that IV NAD+ produces superior clinical outcomes versus oral precursors for any indication.
Why some physicians still prefer IV for specific contexts: in addiction recovery, where the protocol descends from O'Hollaren's 1961 work, the rationale is rapid replenishment during a window of acute neurochemical stress. For acute cognitive complaints, such as post-concussion, chemo-fog, or post-acute COVID, clinicians sometimes prefer IV for the same reason: a high concentration delivered quickly, where waiting six weeks for oral supplementation to build tissue levels may not align with the clinical window.
Frequently Asked Questions
How much does NAD+ IV therapy cost in Vancouver and BC?
NAD+ IV therapy in British Columbia typically costs between $350 and $1,200 per session, depending on the dose (250mg to 1000mg), infusion duration, and clinic location. Vancouver clinics tend to price at the higher end of this range. Many clinics offer package discounts for multiple sessions, and some integrate NAD+ into broader longevity or addiction recovery protocols with different pricing structures.
Is NAD+ IV therapy covered by MSP in British Columbia?
No, NAD+ IV therapy is not covered by the BC Medical Services Plan (MSP). This is considered an elective wellness service and must be paid out-of-pocket. Some extended health insurance plans with naturopathic coverage may provide partial reimbursement if the treatment is administered by a licensed naturopathic doctor, but coverage varies significantly by plan.
Do I need a doctor's referral for NAD+ IV therapy in BC?
Most private IV therapy clinics in BC do not require a physician referral for NAD+ infusions. However, reputable clinics will conduct a health screening, review your medical history, and may require bloodwork before administering treatment. Some clinics have an on-site physician or nurse practitioner who provides medical oversight.
How long does an NAD+ IV infusion take?
A standard NAD+ IV infusion takes between 2 and 4 hours, depending on the dose and your individual tolerance. Higher doses (750mg to 1000mg) typically require slower infusion rates to minimize side effects such as chest tightness, nausea, or flushing. Some clinics offer "express" lower-dose protocols that take 60 to 90 minutes.
What are the side effects of NAD+ IV therapy?
Common side effects during NAD+ infusions include chest tightness, nausea, abdominal cramping, flushing, and lightheadedness. These effects are typically dose-dependent and resolve when the infusion rate is slowed. Serious adverse events are rare when treatment is administered by trained professionals in a clinical setting. If you experience concerning symptoms, contact HealthLinkBC at 8-1-1.
Is NAD+ IV therapy scientifically proven to work?
The scientific evidence for IV NAD+ in humans remains preliminary. While NAD+ is biologically essential and declines with age, published randomized controlled trials specifically examining IV NAD+ clinical outcomes are limited. Most human studies to date focus on pharmacokinetics rather than long-term health outcomes. Consult a healthcare professional to discuss whether the current evidence supports this treatment for your specific goals.
What is the difference between NAD+ IV therapy and oral NMN or NR supplements?
IV NAD+ delivers the intact molecule directly into your bloodstream with 100% bioavailability, while oral precursors like NMN and NR must be converted to NAD+ through metabolic pathways after digestion. However, recent research suggests oral precursors may reach certain tissues more efficiently than IV NAD+, which is rapidly metabolized. No published human trials directly compare clinical outcomes between the two delivery methods.
Who should avoid NAD+ IV therapy?
Individuals who are pregnant or breastfeeding, those with certain cardiac conditions, people taking medications that may interact with NAD+ metabolism, and those with a history of severe reactions to IV therapies should consult a physician before considering NAD+ infusions. A thorough health screening by a qualified healthcare provider is essential before any IV therapy.
Health Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. For health information and advice, call HealthLinkBC at 8-1-1.